Cargando…
Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
Diphencyprone has been reported as a local immunotherapy for cutaneous melanoma metastases. We aim to report cases of melanoma patients treated with diphencyprone in a single Brazilian institution and highlight their outcomes. Since 2012, we have treated 16 melanoma patients with cutaneous metastase...
Autores principales: | Gibbons, Ivana Lameiras, Sonagli, Marina, Bertolli, Eduardo, de Macedo, Mariana Petaccia, Pinto, Clovis Antonio Lopes, Duprat Neto, João Pedreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916415/ https://www.ncbi.nlm.nih.gov/pubmed/29723355 http://dx.doi.org/10.1590/abd1806-4841.20187162 |
Ejemplares similares
-
Vemurafenib and cutaneous adverse events - report of five cases
por: Silva, Giselle de Barros, et al.
Publicado: (2015) -
Intraoperative assessment of surgical margins using “en face” frozen sections in the management of cutaneous carcinomas()
por: Otsuka, Ana Carolina Vasconcellos Guedes, et al.
Publicado: (2022) -
How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system()()
por: Antonialli, Amanda Zorzetto, et al.
Publicado: (2020) -
Dermatofibrosarcoma protuberans of the vulva: margins assessment and reconstructive options – a report of two cases
por: Bertolli, Eduardo, et al.
Publicado: (2014) -
Topical Diphencyprone as an Effective Treatment for Cutaneous Metastatic Melanoma
por: Kim, Young Jin
Publicado: (2012)